Health
Using SARS-CoV-2 epitope to construct a vaccine – News-Medical.Net
A new study published on the preprint server bioRxiv* in August 2020 reports the use of prediction and advanced simulation techniques to identify a novel T cell epitope on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could serve as th…
A new study published on the preprint server bioRxiv* in August 2020 reports the use of prediction and advanced simulation techniques to identify a novel T cell epitope on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could serve as the basis for a customized vaccine with broad-based efficacy.
The SARS-CoV-2 virus infects the human host cell via its interaction with the host cell membrane. The viral envelope is made up of spike protein as well as membrane (M) and envelop…
-
Business22 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News21 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
General9 hours agoAsia stocks plunge, HK suffers steepest fall since 1997
-
Noosa News14 hours agoDistress call sparks rescue operation for capsized sailor near North Stradbroke Island